ERBB2 and Langer mesomelic dysplasia: Intrathecal administration continues to be a mainstay therapy for patients suffering from neoplastic meningitis and has been used in patients with human epidermal growth factor receptor 2-positive (HER2-positive) breast cancer leptomeningeal disease (LMD) and CNS lymphoma [112,113].